X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-29 | SLBT | Sl Science Holding Ltd | Wang Ching-Dong | CEO, 10% | P - Purchase | $2,272,650.00 | +4,545,306 | 333,832,129 | +1% | +$2,147,483,647 | ||||||
2026-09-30 | XENE | Xenon Pharmaceuticals Inc. | Mortimer Ian | Pres, CEO | P - Purchase | $37.38 | +30,000 | 64,223 | +88% | +$1,121,400 | ||||||
2026-09-30 | XENE | Xenon Pharmaceuticals Inc. | Kelly Thomas Patrick | CFO | P - Purchase | $37.32 | +15,000 | 15,000 | New | +$559,740 | ||||||
| M | 2026-09-30 | CRESY | Cresud Inc | Elsztain Alejandro Gustavo | CEO | P - Purchase | $11.50 | +17,334 | 1,243,098 | +1% | +$199,282 | |||||
2026-09-30 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.34 | +7,443 | 15,883 | +88% | +$9,945 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |